GlassScriptPhysician profile
David Michael Mecka
NPI 1215556634
$2,122.10
in general payments reported to CMS, 2019-2025
13 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $312 · 2023: $957 · 2024: $358 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $537.28 | 2022-2024 | Linq II |
| Boston Scientific Corporation | $407.92 | 2022-2025 | General - Vascular Intervention, Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $331.02 | 2023-2025 | Lifevest |
| Edwards Lifesciences Corporation | $214.07 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $146.44 | 2023 | Xarelto |
| Abiomed | $111.31 | 2025 | |
| Cvrx, INC. | $93.51 | 2022-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $91.95 | 2023 | Camzyos |
| Alnylam Pharmaceuticals INC. | $79.09 | 2023 | Amvuttra |
| Amgen INC. | $41.63 | 2024-2025 | Repatha, Repatha |
| Kestra Medical Technology Services, INC. | $24.78 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $22.99 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $20.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mecka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.